Abiopharma

Ryder to Release Second Quarter 2026 Earnings on July 23, 2026

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Directors Interests - Mr Gordon Blaikie

Change - Announcement of Appointment: Appointment of Executive Director and Group Chief Executive Officer - Ong Choon Yi (Wang Junyi)

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Cessation of Substantial Shareholder - Yee Pinh Jeremy

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Cessation of Substantial Shareholder - Chen Johnson

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Becoming a Substantial Shareholder - Vitters Sim Yu Xiong

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Becoming a Substantial Shareholder - Ong Choon Yi (Wang Junyi)

BD Awarded Vizient Innovative Technology Contract for CentroVenaOne™ Insertion System

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Disclosure of Change in Interest of Substantial Shareholders-Coop International & Bonvests Holdings

Net Asset Value(s)